Home0L8 • FRA
add
Lantheus Holdings Inc
Nakaraang pagsara
€48.88
Sakop ng araw
€48.47 - €48.47
Sakop ng taon
€41.91 - €106.75
Market cap
3.81B USD
Average na Volume
28.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 378.04M | -4.07% |
Gastos sa pagpapatakbo | 153.04M | 0.00% |
Net na kita | 78.76M | 26.87% |
Net profit margin | 20.83 | 32.25% |
Kita sa bawat share | 1.57 | -12.78% |
EBITDA | 101.20M | -13.91% |
Aktuwal na % ng binabayarang buwis | 24.65% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 695.57M | -8.12% |
Kabuuang asset | 2.12B | 9.09% |
Kabuuang sagutin | 949.29M | 3.96% |
Kabuuang equity | 1.17B | — |
Natitirang share | 67.99M | — |
Presyo para makapag-book | 2.85 | — |
Return on assets | 10.54% | — |
Return on capital | 12.35% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 78.76M | 26.87% |
Cash mula sa mga operasyon | 87.11M | 2.82% |
Cash mula sa pag-invest | -232.47M | -415.62% |
Cash mula sa financing | -98.41M | -99,507.07% |
Net change in cash | -242.95M | -726.97% |
Malayang cash flow | 86.28M | 164.00% |
Tungkol
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.
Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
Itinatag
1956
Headquarters
Website
Mga Empleyado
808
